by Steven | Nov 7, 2024 | Uncategorized
Psilocybin Relevant Studies Chapter 4: Psilocybin Serotonin Receptor Agonism Relevant studies include: Nichols, D. E. (2016). “Psychedelics.” Pharmacological Reviews, 68(2), 264-355. This comprehensive review discusses how psilocybin and other psychedelics...
by Steven | Nov 6, 2024 | Breaking Through Trauma, Chapter 5 - MDMA, MDMA
MDMA - The Empathogen for Healing Trauma In this chapter, we introduce MDMA therapy, exploring its promise as a unique empathogen-assisted treatment for PTSD. Known for its ability to enhance empathy, emotional openness, and connection, MDMA facilitates an environment...
by Steven | Nov 6, 2024 | Chapter 5 - MDMA, References
Chapter 4: Psilocybin Relevant MDMA Studies MDMA’s Emergence as a Therapeutic Tool for PTSD: MDMA works by reducing the fear response commonly associated with traumatic memories Mitchell, J. M., Bogenschutz, M., Lilienstein, A., Harrison, C., Kleiman, S.,...
by Steven | Nov 6, 2024 | MDMA
The FDA’s recent decision to deny approval for MDMA-assisted therapy as a treatment for PTSD has stirred significant controversy, especially among mental health advocates and research organizations. This decision comes despite promising data from two Phase 3...
by Steven | Nov 3, 2024 | Chapter 4
In this chapter, we explore psilocybin’s role in PTSD treatment, diving into its origins, unique effects on the brain, and therapeutic benefits. We discuss how psilocybin—once used in ancient cultures for healing—has re-emerged in modern psychiatry as a potential...
